Subrata Panda &Amp; Sohini Das

Stories by Subrata Panda &Amp; Sohini Das

Buying health cover? Here's some good news for you

Buying health cover? Here's some good news for you

Rediff.com   20 May 2019

Irdai has listed diseases that can't be excluded from health insurance policies, including neurodevelopmental disorders, mental illness problems, psychological disorders, genetic diseases, puberty- and menopause-related disorders.

2 reasons why drug sales are in poor health

2 reasons why drug sales are in poor health

Rediff.com   11 May 2019

Overall slowdown in the economy and growing volumes of unbranded generic medicines in the domestic market are behind poor sales.

How Saridon has managed to remain top of the mind

How Saridon has managed to remain top of the mind

Rediff.com   3 May 2019

What has worked though for Brand Saridon has been its single-minded focus on headaches as opposed to other analgesics that dwell on a wider set of problems, reports Sohini Das.

Can Vodafone Idea reap synergy benefits?

Can Vodafone Idea reap synergy benefits?

Rediff.com   23 Apr 2019

India's largest telecom operator in terms of subscriber numbers has been struggling to raise its share of subscribers in the market for fourth-generation technology services.

MNC pharma cos may be afflicted by pneumonia virus

MNC pharma cos may be afflicted by pneumonia virus

Rediff.com   22 Apr 2019

Aurobindo Pharma, Cadila Healthcare and Serum Institute are readying their vaccine candidates.

Why Jio may now have to buy spectrum from the open market

Why Jio may now have to buy spectrum from the open market

Rediff.com   20 Apr 2019

While the company insisted it had enough spectrum across circles, analysts said the company might soon need to acquire some spectrum to ensure uninterrupted service.

Raymond forays into real estate with Thane project

Raymond forays into real estate with Thane project

Rediff.com   4 Apr 2019

The project will house 3,000 residential units across 10 towers in the first phase on a 20-acre land parcel that Raymond owns in Thane

New life insurance regulations get Irdai's nod

New life insurance regulations get Irdai's nod

Rediff.com   29 Mar 2019

The new regulations will allow the insurers to charge an extra premium from policyholders who wish to buy riders with unit-linked insurance plans.

Insurance cos shift focus from market-linked products

Insurance cos shift focus from market-linked products

Rediff.com   15 Mar 2019

Market-linked products have been driving the growth of private insurers for some time now. But, the market volatility has forced the companies to re-think their strategies, reports Subrata Panda.

Why cold wave across US is good news for Indian drug cos

Why cold wave across US is good news for Indian drug cos

Rediff.com   12 Mar 2019

Companies such as Cadila Healthcare, Lupin, and Natco, which sell generic versions of flu medication in the US market, are likely to benefit.

India-Pakistan tensions may not impact insurance covers, say experts

India-Pakistan tensions may not impact insurance covers, say experts

Rediff.com   1 Mar 2019

All covers have a war exclusion clause. For cargo, shipping, and aviation industries, war schemes are available.

Jio likely to grab 51% revenue market share in 3 years

Jio likely to grab 51% revenue market share in 3 years

Rediff.com   7 Jan 2019

Airtel and Vodafone Idea are also trying to expand the penetration of 4G users in their subscriber base as they take this network to the hinterland

As shares plunge to 5-year low, Sun Pharma promoters poorer by Rs 12,660 crore in 10 days

As shares plunge to 5-year low, Sun Pharma promoters poorer by Rs 12,660 crore in 10 days

Rediff.com   6 Dec 2018

Sun Pharma's market capitalisation stood at Rs 100,050 crore on December 5, with its share price closing at Rs 417 a piece - lowest since March 2013.

Bhavdeep Singh, the CEO who championed organ donation quits Fortis

Bhavdeep Singh, the CEO who championed organ donation quits Fortis

Rediff.com   9 Nov 2018

Singh, who was instrumental in building required capabilities in the organisation said his role at Fortis did not allow him to spend time with his family, as the reason behind his resignation.

J&J's loss may be good news for Indian pharmas

J&J's loss may be good news for Indian pharmas

Rediff.com   1 Nov 2018

Dr Reddy's, Glenmark, Wockhardt have lined up alternatives for Zytiga

Why drug firms' Q2 revenue growth is likely to dip

Why drug firms' Q2 revenue growth is likely to dip

Rediff.com   12 Oct 2018

Currency played an important role in Q2, with US dollar, Japanese yen and euro appreciating vis-a-vis the Indian rupee, while the Brazilian real, South African rand and Russian ruble depreciating against rupee.

Quality perceptions hobble Jan Aushadi drugs

Quality perceptions hobble Jan Aushadi drugs

Rediff.com   10 Oct 2018

Large pharmaceutical firms feel that if the quality parameters and assurance levels are brought up to the level of branded generics, then Jan Aushadhi medicines would find it difficult to retain their affordability.

Why draft pharma policy may take time to see light of day

Why draft pharma policy may take time to see light of day

Rediff.com   25 Sep 2018

Some of the proposals (for example trade margin calculation for imported medical devices) were not approved by the PMO and were sent back for revisions.

How Amul is quelling the 'non-veg' rumours

How Amul is quelling the 'non-veg' rumours

Rediff.com   21 Sep 2018

This is not the first time Gujarat Cooperative Milk Marketing Federation that owns brand Amul has chosen an unconventional method to protect its brand.

For Singh brothers, truce is temporary, split only way out

For Singh brothers, truce is temporary, split only way out

Rediff.com   15 Sep 2018

NCLT allows Shivinder to withdraw petition against his brother Malvinder. Final decision to be taken by family members in their presence.